Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2026-03-13
• Last 15 days FTD volume: A$4.02 M
• Last 3 months FTD volume: A$7.76 M
• Last 12 months FTD volume: A$22.99 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	A$45.54 M	A$0.11 B	🇺🇸 USA
Thermo Fisher Scientific TMO	A$5.59 M	A$58.02 M	🇺🇸 USA
General Electric GE	A$36.12 M	A$0.26 B	🇺🇸 USA
Bristol-Myers Squibb BMY	A$42.45 M	A$72.09 M	🇺🇸 USA
Sangamo Therapeutics SGMO	A$0.4 M	A$8.24 M	🇺🇸 USA
Novavax NVAX	A$16.56 M	A$66.56 M	🇺🇸 USA
Neurocrine Biosciences NBIX	A$4.15 M	A$27.32 M	🇺🇸 USA
Bio-Techne TECH	A$5.73 M	A$24.33 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$1.4 M	A$14.03 M	🇺🇸 USA
Charles River Laboratories CRL	A$15.9 M	A$0.16 B	🇺🇸 USA